Qrono, Inc.
Pittsburgh, PA Doing business as Qrono Inc. Qrono, Inc.
- UEI
- S8NSYCMSNF79
- CAGE
- 6BR38, 7LQW7
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2403 Sidney St #255, Pittsburgh, PA 15203, USA
- Website
- qrono.com
- Founded
- 2010
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Restoring tolerance in inflammatory bowel disease with an oral ampk agonist nanomedicine that targets antigen presenting… | National Institute of Diabetes and Digestive and Kidney Diseases | $1,221,813 | |
| Restoring tolerance with an oral ampk agonist nanomedicine targeting intestinal dendritic cells as a preventative… | National Institute of Allergy and Infectious Diseases | $306,500 | |
| Definitive Contract 75N93023C00034 | National Institute of Allergy and Infectious Diseases | $599,945 | |
| APC specific mtop inhibition potentiates immune response to IIV in elderly recipients. | National Institute of Allergy and Infectious Diseases | $597,598 | |
| Failed tubulin inhibitor reformulated as localized adjuvant therapy for head and neck cancer | National Cancer Institute | $1,496,236 |
About Qrono, Inc.
Qrono, Inc. is a for-profit corporate entity registered in SAM.gov since March 2011, specializing in medical and scientific research and development, with a particular focus on innovative drug delivery systems and immunotherapy approaches. The company develops targeted nanomedicine technologies that aim to address complex medical challenges, primarily in the domains of autoimmune and inflammatory diseases. Through federal contract and grant awards, Qrono, Inc. provides advanced research services to civilian federal agencies, with a primary emphasis on developing novel therapeutic interventions that target specific cellular mechanisms.
In terms of federal contract awards, Qrono, Inc. has secured multiple contracts with the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services. These contracts have been predominantly research-oriented, including a $599,945 firm fixed price definitive contract focused on screening tolerogenic adjuvants to enhance antigen-specific immunotherapy for celiac disease. Another contract valued at $597,598 was awarded as a total small business set-aside, investigating APC-specific MTOP inhibition to enhance immune response to influenza vaccines in elderly recipients. The contracts demonstrate the company's expertise in conducting specialized medical research projects with precise scientific objectives.
Regarding federal grant awards, Qrono, Inc. has received project grants from agencies like the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Allergy and Infectious Diseases (NIAID). These grants support the development of innovative oral nanomedicine technologies targeting specific cellular pathways. Notable grants include a $919,404 project to develop an oral nanomedicine targeting antigen-presenting cells for treating inflammatory bowel disease and a $306,500 grant to develop a preventative therapy for type 1 diabetes using a dendritic cell-specific AMPK pathway agonist. These grants underscore Qrono's commitment to developing first-in-class immunotherapies that address critical gaps in current medical treatment approaches, with a particular focus on restoring cellular tolerance and mitigating inflammatory responses.
Quick answers
What is Qrono, Inc.'s UEI?
Qrono, Inc.'s Unique Entity ID (UEI) in SAM.gov is S8NSYCMSNF79.
What are Qrono, Inc.'s CAGE codes?
Qrono, Inc.'s CAGE codes are 6BR38 and 7LQW7.
What is Qrono, Inc.'s primary NAICS code?
Qrono, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Qrono, Inc. located?
Qrono, Inc.'s physical address in SAM.gov is 2403 Sidney St #255, Pittsburgh, PA 15203, USA.
Is Qrono, Inc. registered in SAM.gov?
Yes. Qrono, Inc.'s SAM.gov registration is active through February 3, 2027.
What is Qrono, Inc.'s most recent federal award?
Qrono, Inc.'s most recent federal grant award is Restoring tolerance in inflammatory bowel disease with an oral ampk agonist nanomedicine that targets antigen presenting… (R41DK142311), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 20, 2024.
On GovTribe
See Qrono, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors